PND21 PRODUCT ENHANCEMENTS DECREASE THE INCIDENCE OF INJECTION SITE REACTIONS AND PAIN RESULTING IN IMPROVED ADHERENCE TO THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS
Abstract
Authors
J Scanzillo R Bennett P Biancucci V Divan S Sherman A ALSabbagh